CAMP - NASDAQ
CAMP4 Therapeutics Corporation
$4.24
+1.7%CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
At a Glance
Live SnapshotCAMP4 Therapeutics Corporation Management Team
Mr. Caleb Moore
Chief Business Operations Officer & SVice President of Portfolio Strategy & Business Operations
Mr. Joshua Mandel-Brehm
Chief Executive Officer, President & Director
Compensation
$1,889,994
Ms. Kelly Gold
Chief Financial Officer
Compensation
$905,532
Dr. Yuri Maricich M.B.A., M.D.
Chief Medical Officer
Compensation
$822,425
Dr. David Bumcrot Ph.D.
Chief Scientific Officer & Senior Vice President of Research
Compensation
$501,933
Dr. Leonard I. Zon M.D.
Founder & Chairman of Scientific Advisory Board
Dr. Richard A. Young Ph.D.
Founder & Independent Director
Compensation
$143,051
Ms. Michelle Gates
Senior Vice President & Chief People Officer
Dr. Satya Kuchimanchi Ph.D.
Senior Vice President of Technical Operations
Dr. Daniel Tardiff Ph.D.
Vice President & Head of Discovery
CAMP4 Therapeutics Corporation Insider Positioning
During the last 12 months, insiders have purchased $9.43M and sold $18K worth of CAMP shares, resulting in $9.41M of net buying activity.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
6.1M
9.32M
5.0K
17.65K
+9.3M
+$9.30M
9-12 Months
72.0K
112.32K
0
0.00
+112K
+$112K
Top Buyers
Schwab Andrew J.
Director, 10 Percent Owner:
$4.51M
5Am Partners Vi, Llc
10 Percent Owner
$4.50M
Nashat Amir
Director, 10 Percent Owner:
$145K
Polaris Management Co. Vii, L.L.C.
10 Percent Owner
$131K
Young Richard A
Director
$39K
Top Sellers
Tardiff Daniel
Officer: Chief Scientific Officer
$18K
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $9.41M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Insider Participation
5 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
SEC Filings
CAMP - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | June 10, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 30, 2025 | June 11, 2025 | 2025 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.